Floatz logo

849 assets in Breast Cancer

Therapeutic assets addressing Breast Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Darolutamide
Breast Cancer
Vandana AbramsonP2BBB (73)
Palbociclib
Breast Cancer
Hoffmann-La RocheP4BB (71)
Pertuzumab
Breast Cancer
SWOG Cancer Research NetworkP4BB (71)
Goserelin
Breast Cancer
TerSera Therapeutics LLCP4BB (70)
Oxaliplatin
Breast Cancer
Beijing Biostar Pharmaceuticals Co., Ltd.P4BB (70)
Ribociclib
Breast Cancer
National Cancer Institute (NCI)P4BB (70)
Trastuzumab Duocarmazine
Breast Cancer
Byondis B.V.P3BB (70)
Anastrozole
Breast Cancer
National Cancer Institute (NCI)P4BB (69)
Carboplatin
Breast Cancer
AkesoP4BB (69)
Cyclophosphamide
Breast Cancer
Fudan UniversityP4BB (69)
Eribulin
Breast Cancer
Sun Yat-sen UniversityP4BB (69)
Eribulin Monomethanesulfonate
Breast Cancer
Henan Cancer HospitalP4BB (69)
Fulvestrant
Breast Cancer
MedSIRP4BB (69)
Letrozole
Breast Cancer
National Cancer Institute (NCI)P4BB (69)
Leuporelin
Breast Cancer
Fudan UniversityP4BB (69)
Loratadine
Breast Cancer
Noha MansourP2BB (69)
Tamoxifen
Breast Cancer
Dana-Farber Cancer InstituteP4BB (69)
Trastuzumab
Breast Cancer
SWOG Cancer Research NetworkP4BB (69)
Vitamin D
Breast Cancer
University of Illinois at ChicagoP4BB (69)
Adriamycin
Breast Cancer
George Washington UniversityP4BB (68)
Camizestrant
Breast Cancer
AstraZenecaP3BB (68)
Fluorouracilum
Breast Cancer
PfizerP4BB (68)
Marcaine
Breast Cancer
Ospedale di CamposampieroP4BB (68)
Capecitabine
Breast Cancer
University of Vermont Medical CenterP4BB (67)
Cis-Diamminedichloroplatinum Ii
Breast Cancer
Tianjin Medical University Cancer Institute and HospitalP3BB (67)
Docetaxel
Breast Cancer
Fudan UniversityP4BB (67)
Epirubicin
Breast Cancer
Ohio State University Comprehensive Cancer CenterP4BB (67)
Everolimus
Breast Cancer
UNC Lineberger Comprehensive Cancer CenterP4BB (67)
Exemestane
Breast Cancer
National Cancer Institute (NCI)P4BB (67)
Immunoglobulin G1, Anti-(Human Epidermal Growth Factor Receptor Her2) (Human-Mus Musculus Monoclonal Shr-1805 ?1-Chain), Complex With Human-Mus Musculus Monoclonal Shr-1805 ?-Chain, Dimer, Thioether With N-[6-(3-Mercapto-2,5-Dioxo-1-Pyrrolidinyl)-1-Oxohexyl]Glycylglycyl-L-Phenylalanyl-N-[[(1R)-1-Cyclopropyl-2-[[(1S,9S)-9-Ethyl-5-Fluoro-2,3,9,10,13,15-Hexahydro-9-Hydroxy-4-Methyl-10,13-Dioxo-1H,12H-Benzo[De]Pyrano[3?,4?:6,7]Indolizino[1,2-B]Quinolin-1-Yl]Amino]-2-Oxoethoxy]Methyl]Glycinamide
Breast Cancer
Fudan UniversityP4BB (67)
Irinotecan
Breast Cancer
PfizerP4BB (67)
Lidocaine
Breast Cancer
Instituto Nacional de Cancer, BrazilP4BB (67)
Methotrexate
Breast Cancer
University of Illinois at ChicagoP3BB (67)
Nivestim
Breast Cancer
MedSIRP4BB (67)
Pegfilgrastim
Breast Cancer
Yeon Hee ParkP4BB (67)
Phosphonic Acid, P-[3-[[(2R,3R)-2-[(1R)-1-[3,5-Bis(Trifluoromethyl)Phenyl]Ethoxy]-3-(4-Fluorophenyl)-4-Morpholinyl]Methyl]-2,5-Dihydro-5-Oxo-1H-1,2,4-Triazol-1-Yl]-
Breast Cancer
Chinese University of Hong KongP4BB (67)
Thiotepa
Breast Cancer
The Netherlands Cancer InstituteP3BB (67)
Vinorelbine Ditartrate
Breast Cancer
CSPC Megalith Biopharmaceutical Co.,Ltd.P4BB (67)
Zoledronate
Breast Cancer
Xijing HospitalP4BB (67)
Alpelisib
Breast Cancer
M.D. Anderson Cancer CenterP4BB (66)
Calcium
Breast Cancer
University of Illinois at ChicagoP4BB (66)
Cytarabine
Breast Cancer
Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd.P4BB (66)
Dexmedetomidine
Breast Cancer
Tianjin Medical University Cancer Institute and HospitalP4BB (66)
Elacestrant
Breast Cancer
iOMEDICO AGP3BB (66)
Inetetamab
Breast Cancer
Fudan UniversityP4BB (66)
Olaparib
Breast Cancer
The Netherlands Cancer InstituteP4BB (66)
Panitumumab
Breast Cancer
National Cancer Institute (NCI)P2BB (66)
Pelareorep
Breast Cancer
Adlai Nortye Biopharma Co., Ltd.P2BB (66)
Tislelizumab
Breast Cancer
National University Hospital, SingaporeP4BB (66)
tqb3616
Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.P3BB (66)
Showing 1 to 50 of 849 assets
PreviousPage 1 of 17Next